R.A.W. Biomed Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Seed
  • (Upcoming)

  • Latest Deal Amount
  • $3.71M

  • Investors
  • 4

R.A.W. Biomed General Information

Description

Developer of an advanced imaging platform designed to increase the precision of minimally invasive interventional radiology procedures. The company's platform offers a 3D augmented reality navigation system to assist the physician in positioning a percutaneous device into the body and easily visualize each anatomical structure and an imaging software for 3D reconstruction, planning and verification of the ablation procedure, enabling healthcare providers to reduce risks and possible errors by ensuring safety, accessibility and outcomes comparable to open surgery.

Contact Information

Website
www.rawbiomed.com
Formerly Known As
Endosight
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Via Soperga 13
  • 20127 Milan(Milano)
  • Italy
+39 340
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Augmented Reality, TMT, HealthTech, Life Sciences
Corporate Office
  • Via Soperga 13
  • 20127 Milan(Milano)
  • Italy
+39 340

R.A.W. Biomed Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

R.A.W. Biomed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Seed Round $3.71M Upcoming Generating Revenue
10. Debt - General 12-Mar-2026 Completed Generating Revenue
9. Debt Repayment 31-Dec-2025 Completed Generating Revenue
8. Debt Conversion 23-Dec-2025 Completed
7. Accelerator/Incubator 30-Apr-2025 Completed Product In Beta Test
6. Debt - General 30-Sep-2024 Completed Product In Beta Test
5. Debt - General 22-Apr-2022 Completed Pre-Clinical Trials
4. Debt - General 30-Jun-2021 Completed Product In Beta Test
3. Angel (individual) 03-Aug-2017 $1.91M $1.92M Completed Startup
2. Accelerator/Incubator 01-Jan-2016 $12.3K Completed Startup
To view R.A.W. Biomed’s complete valuation and funding history, request access »

R.A.W. Biomed Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an advanced imaging platform designed to increase the precision of minimally invasive interventional radiol
Therapeutic Devices
Milan, Italy
13 As of 2026

Kitzbuhel, Austria
 

Bern, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

R.A.W. Biomed Competitors (7)

One of R.A.W. Biomed’s 7 competitors is Interventional Systems, a Venture Capital-Backed company based in Kitzbuhel, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Interventional Systems Venture Capital-Backed Kitzbuhel, Austria
CAScination Accelerator/Incubator Backed Bern, Switzerland
Quantum Surgical Venture Capital-Backed Montpellier, France
MediView Venture Capital-Backed Cleveland, OH
Edda Technology Venture Capital-Backed Princeton, NJ
You’re viewing 5 of 7 competitors. Get the full list »

R.A.W. Biomed Patents

  • 18

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

R.A.W. Biomed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022112859-A1 Control of a surgical instrument Inactive 27-Nov-2020
JP-2020507403-A System and method for processing data from a computed tomography scan Pending 10-Feb-2017
EP-3580721-A1 System and method for processing data from computed tomography scans Active 10-Feb-2017
EP-3580721-B1 System and method for processing data from computed tomography scans Active 10-Feb-2017
EP-3580721-C0 System and method for processing data from computed tomography scans Active 10-Feb-2017 A61B6/5211
To view R.A.W. Biomed’s complete patent history, request access »

R.A.W. Biomed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

R.A.W. Biomed Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Invitalia Not-For-Profit Venture Capital Minority
MedTech Innovator Accelerator/Incubator
InnoVits Accelerator/Incubator Minority
UniCredit Start Lab Accelerator/Incubator
To view R.A.W. Biomed’s complete investors history, request access »

Ready to get started?

Request a free trial

R.A.W. Biomed FAQs

  • When was R.A.W. Biomed founded?

    R.A.W. Biomed was founded in 2015.

  • Where is R.A.W. Biomed headquartered?

    R.A.W. Biomed is headquartered in Milan, Italy.

  • What is the size of R.A.W. Biomed?

    R.A.W. Biomed has 13 total employees.

  • What industry is R.A.W. Biomed in?

    R.A.W. Biomed’s primary industry is Therapeutic Devices.

  • Is R.A.W. Biomed a private or public company?

    R.A.W. Biomed is a Private company.

  • What is R.A.W. Biomed’s current revenue?

    The current revenue for R.A.W. Biomed is .

  • How much funding has R.A.W. Biomed raised over time?

    R.A.W. Biomed has raised $4.03M.

  • Who are R.A.W. Biomed’s investors?

    Invitalia, MedTech Innovator, InnoVits, and UniCredit Start Lab have invested in R.A.W. Biomed.

  • Who are R.A.W. Biomed’s competitors?

    Interventional Systems, CAScination, Quantum Surgical, MediView, and Edda Technology are some of the 7 competitors of R.A.W. Biomed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process